Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2014 1
2015 2
2016 1
2017 2
2018 2
2019 2
2020 11
2021 15
2022 3
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators. Jackson DJ, et al. Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7. Lancet. 2024. PMID: 38071986 Free article. Clinical Trial.
Cryoglobulins: putative effectors of adaptive immune response.
Basile U, Napodano C, Marino M, Gulli F, Colantuono S, Casato M, Pocino K, Basile V, Todi L, Rapaccini GL, Visentini M. Basile U, et al. Among authors: colantuono s. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):171-179. doi: 10.55563/clinexprheumatol/keip4u. Epub 2020 Oct 29. Clin Exp Rheumatol. 2021. PMID: 33124568 Free article. Review.
Severe asthma: One disease and multiple definitions.
Bagnasco D, Paggiaro P, Latorre M, Folli C, Testino E, Bassi A, Milanese M, Heffler E, Manfredi A, Riccio AM, De Ferrari L, Blasi F, Canevari RF, Canonica GW, Passalacqua G; SANI (Severe Asthma Network Italy); Severe Asthma Network Italy. Bagnasco D, et al. World Allergy Organ J. 2021 Nov 19;14(11):100606. doi: 10.1016/j.waojou.2021.100606. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34871335 Free PMC article.
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis.
Caruso C, Colantuono S, Tolusso B, Di Mario C, Fancello G, La Sorda M, Celi G, Caringi M, Volterrani A, Descalzi D, Gremese E, Sanguinetti M, Gasbarrini A, Canonica GW. Caruso C, et al. Among authors: colantuono s. World Allergy Organ J. 2023 Jun 15;16(6):100789. doi: 10.1016/j.waojou.2023.100789. eCollection 2023 Jun. World Allergy Organ J. 2023. PMID: 37484874 Free PMC article.
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis.
Caruso C, Laterza L, Settanni CR, Colantuono S, Di Mario C, Tolusso B, Castrì F, Gremese E, Scaldaferri F, Armuzzi A, De Simone C, Peris K, Chiricozzi A, Gasbarrini A. Caruso C, et al. Among authors: colantuono s. Front Immunol. 2023 Jan 11;13:995304. doi: 10.3389/fimmu.2022.995304. eCollection 2022. Front Immunol. 2023. PMID: 36713411 Free PMC article.
46 results